Alteration of cell cycle parameters by 17 beta estradiol (17 be) in a human breast carcinoma line : implications for combination therapy

Author(s):  
R.R. Weichselbaum ◽  
S. Hellman ◽  
A.J. Piro ◽  
J. Nove ◽  
J.B. Little
2002 ◽  
Vol 42 (1) ◽  
pp. 55-64 ◽  
Author(s):  
Chingwen Ying ◽  
Jih-Tay Hsu ◽  
Hsiao-Chiao Hung ◽  
Don-Hei Lin ◽  
Long-Fang Oliver Chen ◽  
...  

Marine Drugs ◽  
2013 ◽  
Vol 11 (11) ◽  
pp. 4570-4584 ◽  
Author(s):  
Wenxia Sun ◽  
Cuiting Lv ◽  
Tonghan Zhu ◽  
Xue Yang ◽  
Shanjian Wei ◽  
...  

2017 ◽  
Vol 2017 ◽  
pp. 1-13 ◽  
Author(s):  
Jignesh Lunagariya ◽  
Xiaojian Liao ◽  
Weili Long ◽  
Shenghui Zhong ◽  
Poonam Bhadja ◽  
...  

Herein, we report the cytotoxicity of cyclopentapeptide analogues of marine natural product galaxamide towards breast carcinoma cells and the underlying mechanisms. We examined the effect of the novel galaxamide analogues on cancer cell proliferation by MTT assay and also further examined the most active compound for morphological changes using Hoechst33342 staining technique, induction of apoptosis, cell cycle phases, mitochondrial membrane potential (MMP), and reactive oxygen species (ROS) generation using flow cytometry in human breast cancer MCF-7 cells in vitro. Galaxamide and its analogues effectively induced toxicity in human hepatocellular carcinoma HepG2, human breast carcinoma MCF-7, human epitheloid cervix carcinoma HeLa, and human breast carcinoma MB-MDA-231 cell lines. Amongst them, compound 3 exhibited excellent toxicity towards MCF-7 cells. This galaxamide analogue significantly induced apoptosis in a dose-dependent manner in MCF-7 cells involves cell cycle arrest in the G1 phase, a reduction of MMP, and a marked increase in generation of ROS. Particularly, compound 3 of galaxamide analogues might be a potential candidate for the treatment of breast cancer.


2011 ◽  
Vol 2011 ◽  
pp. 1-7 ◽  
Author(s):  
Cheng Wang ◽  
Jing Wang ◽  
Han Jiang ◽  
Min Zhu ◽  
Baoguo Chen ◽  
...  

Many radiopharmaceuticals used for medical diagnosis and therapy are beta emitters; however, the mechanism of the cell death caused by beta-irradiation is not well understood. The objective of this study was to investigate the apoptosis of human breast carcinoma MCF-7 cell lines induced by Strontium-89 (89Sr) and its regulation and control mechanism. High-metastatic Breast Carcinoma MCF-7 cells were cultured in vitro using89Sr with different radioactive concentration. The inhibition rate of cell proliferation was measured by MTT color matching method. The cell cycle retardation, apoptosis conditions, mitochondrion transmembrane potential difference and Fas expression were tested and analyzed. The genes P53 and bcl-2 expressions was also analyzed using immunity histochemical analysis. After being induced by89Sr with various of radioactive concentration, it was found that the inhibition of cell proliferation of MCF-7 cells was obviously, the retardation of cell cycle occurred mainly in G2-M. It was also found that the obvious apoptosis occurred after being induced by89Sr, the highest apoptosis rate reached 46.28%. The expressions of Fas acceptor and P53 gene increased, while bcl-2 gene expression decreasesd. These findings demonstrate that in the ranges of a certain radioactive concentration, the inhibition rate of MCF-7 cell proliferation and retardation of cell cycle had positive correlation with the concentration of89Sr. And the mitochondrion transmembrane potential decrease would induce the apoptosis of MCF-7 cell notably, which were controlled by P53 and bcl-2 genes, involved with the Fas acceptor.


2011 ◽  
Vol 35 (10) ◽  
pp. 1025-1029 ◽  
Author(s):  
Reelma Velho‑Pereira ◽  
Amit Kumar ◽  
Badri N. Pandey ◽  
Aarti G. Jagtap ◽  
Kaushala P. Mishra

Sign in / Sign up

Export Citation Format

Share Document